About The Study:

Pneumococcal Disease poses a significant health risk for adults over the age of 50. This bacteria can cause a range of serious illnesses, including pneumonia, meningitis, and bloodstream infections. While it can affect people of all ages, adults over 50 are particularly vulnerable due to factors like weakened immune systems, underlying health conditions, and age-related decline in immunity. Pneumococcal infections can lead to severe complications, hospitalization, and in some cases, even death.

The purpose of this research study is to test the investigational vaccine and see if it will result in covering more strains as compared to currently marketed pneumococcal vaccines. The study is about 6 months long and includes 4 office visits and 6 telephone calls. Throughout the study’s duration, compensation will be provided to cover your time and travel expenses.

Study-related care is available to participants at no cost and health insurance is not required nor needed.


  • Must be 50 years or older
  • In good general health
  • Have had no previous licensed or investigational pneumococcal vaccine
  • *Please note, that other qualifications apply